1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow reslizumab: new trials by email Literature Review of reslizumab trials Research Report on reslizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists Mepolizumab, Reslizumab, Placebo - Healthy Subjects, Pharmacokinetics | Phase 1 | Completed | Food and Drug Administration (FDA) | 72 | 2020-02-17 | 2024-04-22 |
Food and Drug Administration (FDA) (1)
United States (1)